Skip to main content
Clinical Trials/EUCTR2020-005956-39-FR
EUCTR2020-005956-39-FR
Active, Not Recruiting
Phase 1

Treatment of pediatric Post-traumatic Stress Disorder with memory reactivation under the influence of propranolol: A randomized placebo-controlled trial - PPP

CHU Toulouse0 sites92 target enrollmentJanuary 22, 2021

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Post-traumatic Stress Disorder
Sponsor
CHU Toulouse
Enrollment
92
Status
Active, Not Recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
January 22, 2021
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional clinical trial of medicinal product
Sex
All

Investigators

Sponsor
CHU Toulouse

Eligibility Criteria

Inclusion Criteria

  • \-Children aged 7\-12 years
  • \-CPTS\-RI total score \=40
  • \-Primary diagnosis of PTSD (6 months or more after the traumatic event)
  • \-Affiliation to a social security scheme
  • \-Written consent signed by the parents/holders of parental authority and the investigator
  • \-Acceptance of the protocol by the child
  • Are the trial subjects under 18? yes
  • Number of subjects for this age range: 92
  • F.1\.2 Adults (18\-64 years) no
  • F.1\.2\.1 Number of subjects for this age range

Exclusion Criteria

  • \-Age\<7 years or \=13 years
  • \-Child or parents that don’t have a good understanding of the French language according to investigator's opinion
  • \- Children whose parents have been deprived of their authority
  • \-Contraindication to propranolol (cardiogenic shock, sinus bradycardia, hypotension (\< fifth percentile oscillometric or \<2SD) (Banker et al., 2016\)., greater than first\-degree heart block, heart failure, bronchial asthma and hypersensitivity to propranolol hydrochloride)
  • \-Heart Rate/HR\<50 bpm
  • \-Concurrent medication with possible interactions with propranolol
  • \-\-Concurrent psychotropic drugs that have been shown to be effective in improving symptoms of PTSD
  • \-Concurrent psychotherapy (\>1 stuctured session/month declared by the clinician who follows the child)
  • \-Current active psychosis, anorexia nervosa, bulimia nervosa, binge\-eating disorder, attention\-deficit hyperactivity disorder, autism spectrum disorder
  • \-Pregnancy

Outcomes

Primary Outcomes

Not specified

Similar Trials